CNXU
Conexeu Sciences Inc. Common Stock (CNXU)
Healthcare • NASDAQ • $9.49-12.13%
- Symbol
- CNXU
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $9.49
- Daily Change
- -12.13%
- Market Cap
- $290.60M
- Trailing P/E
- N/A
- Forward P/E
- -20.49
- 52W High
- $18.79
- 52W Low
- $9.60
- Analyst Target
- $20.00
- Dividend Yield
- N/A
- Beta
- N/A
Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis. The company's solutions are supported by preclinical and peer-reviewed data and are positioned as alternatives to conventional fillers or implants, with products currently investigation…
Company websiteResearch CNXU on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.